Stay updated on Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Sign up to get notified when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Enrollment is closed as indicated by the new status. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment labeling and revision version to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T14:50:41.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows the updated revision indicator v3.5.5, replacing the previous v3.5.4, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-06-05T09:58:26.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the prior v3.5.3 tag. This indicates a minor page version update rather than any change to the study data.
    Difference
    0.0%
    Check dated 2026-05-14T23:09:09.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page shows a new revision label. It updates from Revision: v3.5.2 to Revision: v3.5.3, signaling a software release rather than substantive changes to the study data or content.
    Difference
    0.0%
    Check dated 2026-04-30T14:26:40.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No user-facing content or layout changes are evident.
    Difference
    0.0%
    Check dated 2026-04-16T10:14:22.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T16:45:37.000Z thumbnail image

Stay in the know with updates to Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.